Skip to main content

Table.3 Influencing factors of SARS-CoV-2 neutralizing antibody immunization by multinomial logistic regression

From: Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial

Variables

OR (95% CI)

OR (95% CI)*

GMT 64–127 (ref: 16–63)

 0–14 group

1.0

1.0

 0–21 group

2.5 (1.5–4.1)

2.5 (1.5–4.1)

 0–28 group

2.1 (1.3–3.3)

2.0 (1.2–3.3)

GMT ≥ 128 (ref: 16–63)

 

 0–14 group

1.0

1.0

 0–21 group

4.5 (2.8–7.1)

4.4 (2.8–7.1)

 0–28 group

3.3 (2.1–5.2)

3.3 (2.1–5.2)

  1. GMT, Geometric mean titer; CI, confidence interval; OR: odds ratio
  2. *Adjusted by age, gender, BMI, marital status, education level, influenza vaccination history, smoking, drinking, and chronic diseases
Back to article page

Infectious Diseases of Poverty

ISSN: 2049-9957

Contact us